BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 23395965)

  • 1. Characterization of a selective CaMKII peptide inhibitor.
    Gomez-Monterrey I; Sala M; Rusciano MR; Monaco S; Maione AS; Iaccarino G; Tortorella P; D'Ursi AM; Scrima M; Carotenuto A; De Rosa G; Bertamino A; Vernieri E; Grieco P; Novellino E; Illario M; Campiglia P
    Eur J Med Chem; 2013 Apr; 62():425-34. PubMed ID: 23395965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure activity relationships of peptidic analogs of MyoD for the development of Id1 inhibitors as antiproliferative agents.
    Hsiao YC; Yang DL; Hung HL; Lung FD
    J Pept Sci; 2013 Nov; 19(11):676-83. PubMed ID: 24123584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DY-9760e inhibits endothelin-1-induced cardiomyocyte hypertrophy through inhibition of CaMKII and ERK activities.
    Lu YM; Shioda N; Han F; Kamata A; Shirasaki Y; Qin ZH; Fukunaga K
    Cardiovasc Ther; 2009; 27(1):17-27. PubMed ID: 19207476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel collagen-binding peptide promotes osteogenic differentiation via Ca2+/calmodulin-dependent protein kinase II/ERK/AP-1 signaling pathway in human bone marrow-derived mesenchymal stem cells.
    Shin MK; Kim MK; Bae YS; Jo I; Lee SJ; Chung CP; Park YJ; Min do S
    Cell Signal; 2008 Apr; 20(4):613-24. PubMed ID: 18248957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving a natural CaMKII inhibitor by random and rational design.
    Coultrap SJ; Bayer KU
    PLoS One; 2011; 6(10):e25245. PubMed ID: 21984908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual mechanism of a natural CaMKII inhibitor.
    Vest RS; Davies KD; O'Leary H; Port JD; Bayer KU
    Mol Biol Cell; 2007 Dec; 18(12):5024-33. PubMed ID: 17942605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and activity relationship of 2-(substituted benzoyl)-hydroxyindoles as novel CaMKII inhibitors.
    Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1456-8. PubMed ID: 21292482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of selective and potent cyclin-dependent kinase inhibitors.
    N'gompaza-Diarra J; Bettayeb K; Gresh N; Meijer L; Oumata N
    Eur J Med Chem; 2012 Oct; 56():210-6. PubMed ID: 22982525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure based optimization of 2-(4-phenoxybenzoyl)-5-hydroxyindole as a novel CaMKII inhibitor.
    Komiya M; Asano S; Koike N; Koga E; Igarashi J; Nakatani S; Isobe Y
    Bioorg Med Chem; 2012 Dec; 20(23):6840-7. PubMed ID: 23088910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin is an inhibitor of calcium/calmodulin dependent protein kinase II.
    Mayadevi M; Sherin DR; Keerthi VS; Rajasekharan KN; Omkumar RV
    Bioorg Med Chem; 2012 Oct; 20(20):6040-7. PubMed ID: 22989913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of potent and selective inhibitors of calmodulin-dependent kinase II (CaMKII).
    Koltun DO; Parkhill EQ; Kalla R; Perry TD; Elzein E; Li X; Simonovich SP; Ziebenhaus C; Hansen TR; Marchand B; Hung WK; Lagpacan L; Hung M; Aoyama RG; Murray BP; Perry JK; Somoza JR; Villaseñor AG; Pagratis N; Zablocki JA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):541-546. PubMed ID: 29254643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the CaMKII/ERK Interaction in the Heart Prevents Cardiac Hypertrophy.
    Cipolletta E; Rusciano MR; Maione AS; Santulli G; Sorriento D; Del Giudice C; Ciccarelli M; Franco A; Crola C; Campiglia P; Sala M; Gomez-Monterrey I; De Luca N; Trimarco B; Iaccarino G; Illario M
    PLoS One; 2015; 10(6):e0130477. PubMed ID: 26110816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of 4-substituted pyrrolo[2,3-a]carbazole Pim kinase inhibitors.
    Giraud F; Akué-Gédu R; Nauton L; Candelon N; Debiton E; Théry V; Anizon F; Moreau P
    Eur J Med Chem; 2012 Oct; 56():225-36. PubMed ID: 22982527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a series of naphthamides as potent, orally active vascular endothelial growth factor receptor-2 tyrosine kinase inhibitors.
    Weiss MM; Harmange JC; Polverino AJ; Bauer D; Berry L; Berry V; Borg G; Bready J; Chen D; Choquette D; Coxon A; DeMelfi T; Doerr N; Estrada J; Flynn J; Graceffa RF; Harriman SP; Kaufman S; La DS; Long A; Neervannan S; Patel VF; Potashman M; Regal K; Roveto PM; Schrag ML; Starnes C; Tasker A; Teffera Y; Whittington DA; Zanon R
    J Med Chem; 2008 Mar; 51(6):1668-80. PubMed ID: 18324759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of guanidino analogues of roscovitine.
    Dolečková I; Cesnek M; Dračinský M; Brynda J; Voller J; Janeba Z; Kryštof V
    Eur J Med Chem; 2013 Apr; 62():443-52. PubMed ID: 23399722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CaMKII-γ mediates phosphorylation of BAD at Ser170 to regulate cytokine-dependent survival and proliferation.
    Hojabrpour P; Waissbluth I; Ghaffari M; Cox ME; Duronio V
    Biochem J; 2012 Feb; 442(1):139-49. PubMed ID: 22103330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.
    Carocci A; Catalano A; Bruno C; Lovece A; Roselli MG; Cavalluzzi MM; De Santis F; De Palma A; Rusciano MR; Illario M; Franchini C; Lentini G
    Bioorg Med Chem; 2013 Feb; 21(4):847-51. PubMed ID: 23332368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Tat peptide immunoconjugates differentially sensitize breast cancer cells to selected antiproliferative agents that induce the cyclin-dependent kinase inhibitor p21WAF-1/CIP-1.
    Hu M; Wang J; Chen P; Reilly RM
    Bioconjug Chem; 2006; 17(5):1280-7. PubMed ID: 16984139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.
    Amin KM; Eissa AA; Abou-Seri SM; Awadallah FM; Hassan GS
    Eur J Med Chem; 2013 Feb; 60():187-98. PubMed ID: 23291120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
    Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
    Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.